Outstanding cancer researcher acknowledged

21/05/2020

Dr Ulf Schmitz, Head of the Centenary Institute’s Computational BioMedicine Laboratory has been recognised as an outstanding investigator in the field of cancer research, being awarded an NHMRC Investigator Grant.

The grant, which will support Dr Schmitz and his exploration of post-transcriptional gene regulation in cancer over the next five years, will commence in 2021.

“Healthy cells normally undergo regulatory processes that turn DNA into proteins but when this process becomes distorted cancer cells are formed. My research is to understand the bio-mechanisms that control this gene regulation activity. By improving our understanding of gene regulation and its role in cancer, we can offer new opportunities for better diagnosis, and treatment,” said Dr Schmitz.

The NHMRC Investigator Grant scheme supports the research programs of outstanding investigators at all career stages with funding as well as research support packages. Further information on the grants can be found on the NHMRC website here.

Information on Dr Schmitz and his research can be found here.

Latest News

Human enzyme DPP4 does not enable COVID-19 infection

Research from the Centenary Institute has found that the human enzyme DPP4 does not enable COVID-19 infection in our bodies.

Prof John Rasko AO and collaborators publish world-first clinical stem cell study

Professor John Rasko AO has led a world-first clinical trial into engineered stem cell treatment use, treating 15 patients with steroid resistant acute graft-versus-host disease.

Enzyme insight could lead to new diabetes treatment

Centenary Institute research has discovered that the lack of an enzyme in the liver called sphingosine kinase 2 results in pronounced insulin resistance and glucose intolerance, both symptoms of early stage type 2 diabetes.

 

News Topics

ALL NEWS

 


Sign up for our latest News